Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection.
Several nucleic-acid based technologies have recently emerged with capabilities for broad virus detection. One of these, high throughput sequencing, has the potential for novel virus detection because this method does not depend upon prior viral sequence knowledge. However, the use of high throughput sequencing for testing biologicals poses greater challenges as compared to other newly introduced tests due to its technical complexities and big data bioinformatics. Thus, the Advanced Virus Detection Technologies Users Group was formed as a joint effort by regulatory and industry scientists to facilitate discussions and provide a forum for sharing data and experiences using advanced new virus detection technologies, with a focus on high throughput sequencing technologies. The group was initiated as a task force that was coordinated by the Parenteral Drug Association and subsequently became the Advanced Virus Detection Technologies Interest Group to continue efforts for using new technologies for detection of adventitious viruses with broader participation, including international government agencies, academia, and technology service providers.
Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD; arifa.khan@fda.hhs.gov dvacante@its.jnj.com.
Arifa S
AS
Khan
Janssen Research & Development, LLC, Malvern, PA; arifa.khan@fda.hhs.gov dvacante@its.jnj.com.
Dominick A
DA
Vacante
GlaxoSmithKline Vaccines, Wavre, Belgium.
Jean-Pol
JP
Cassart
Analytical Research and Development, Sanofi Pasteur. Toronto, ON, Canada.
Siemon H S
SH
Ng
GlaxoSmithKline Vaccines, Rixensart, Belgium; and.
Christophe
C
Lambert
Analytical Research and Development, Sanofi Pasteur. Toronto, ON, Canada.
Robert L
RL
Charlebois
Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD.
Kathryn E
KE
King
D019295:Computational Biology; D059014:High-Throughput Nucleotide Sequencing; D011639:Public Opinion; D013678:Technology, Pharmaceutical; D014780:Viruses / Q000302:isolation & purification*
Adventitious viruses; High throughput sequencing; Massively parallel sequencing; New technologies; Next generation sequencing; Virus detection